|
|
|
|
|
TEARGARD Was The First OTC Artificial Tear To Treat All Three Layers Of The Human Tear Film. The Novel & Proprietary Formulation, With A Lipid Component, Was Developed in 1982 With First InterState USA Sales in 1983 by Bio Products Inc, a subsidiary of the then Ketchum & Co., Inc. InterState USA Sales Continued Through 1987 And Beyond, With Stocking By Most Drug Wholesalers and Numerous Drug Chains. The Trademark/Brand and Formulation Were Sold To MedTech Laboratories in 1987, With Subsequent Sale To Lee Pharmaceuticals. TEARGARD Was Acquired By Aqueous Pharma in 2001. At TEARGARD's Peak In 1986, USA InterState Sales Were Over US Dollars One Million.
|
|
|
|
|
TEARGARD Is A Registered Trademark of Aqueous Pharma. The TEARGARD formula is now available as OptiZen with stocking in several chain drugstores in the USA.
|
|
|
